Knight, Jason S. http://orcid.org/0000-0003-0995-9771
Erkan, Doruk http://orcid.org/0000-0001-7216-677X
Article History
Accepted: 18 March 2024
First Online: 3 May 2024
Competing interests
: J.S.K. has received consulting fees from Argenix, Jazz Pharmaceuticals and Roivant Sciences, and is on the advisory board for Otsuka/Visterra. D.E. has received research grants from, GSK and Exagen, consulting fees from Argenix, Cadrenal and Chugai and royalties from Up-To-Date, and is on the speaker’s bureau for GSK and Aurinia, and the advisory boards for GSK and Otsuka/Visterra.